Barclays PLC Viatris Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Viatris Inc stock. As of the latest transaction made, Barclays PLC holds 100 shares of VTRS stock, worth $1,252. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100

Previous 2,579,495 100.0%

Holding current value

$1,252

Previous $29.9 Million 100.0%

% of portfolio

0.0%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$10.32 - $12.13 $1.48 Million - $1.74 Million	-143,397 Reduced 5.27%	2,579,495 $29.9 Million
Q2 2024 Aug 14, 2024	SELL	$10.05 - $12.02 $5.47 Million - $6.55 Million	-544,512 Reduced 16.66%	2,722,892 $28.9 Million
Q1 2024 May 15, 2024	BUY	$11.27 - $13.53 $1.85 Million - $2.22 Million	163,892 Added 5.28%	3,267,404 $39 Million
Q4 2023 Feb 15, 2024	BUY	$8.77 - $10.85 $7.31 Million - $9.04 Million	833,444 Added 36.71%	3,103,512 $33.6 Million
Q3 2023 Nov 07, 2023	SELL	$9.59 - $11.35 $1.89 Million - $2.24 Million	-197,495 Reduced 8.0%	2,270,068 $22.4 Million
Q2 2023 Aug 03, 2023	BUY	$9.02 - $10.29 $9.2 Million - $10.5 Million	1,020,242 Added 70.49%	2,467,563 $24.6 Million
Q1 2023 May 04, 2023	SELL	$9.2 - $12.26 $5.23 Million - $6.97 Million	-568,774 Reduced 28.21%	1,447,321 $13.9 Million
Q4 2022 Feb 13, 2023	SELL	$8.72 - $11.56 $6.35 Million - $8.42 Million	-728,060 Reduced 26.53%	2,016,095 $22.4 Million
Q3 2022 Nov 03, 2022	BUY	$8.48 - $11.13 $4.1 Million - $5.39 Million	484,035 Added 21.42%	2,744,155 $23.4 Million
Q2 2022 Aug 12, 2022	SELL	$9.95 - $12.27 $9.12 Million - $11.2 Million	-916,649 Reduced 28.85%	2,260,120 $23.7 Million
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $31.2 Million - $48.9 Million	3,176,769 New	3,176,769 $34.6 Million

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account